BackArdent Health Partners Overview

Ardent Health Partners EBIT

Track Ardent Health Partners's EBIT ($230M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$30.63M
73.12% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$232.76M
43.77% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Ardent Health Partners (ARDT) FAQ

As of the most recent data (June 2026), ARDT shows a EBIT of $230M. That compares with $410M in the prior-year period — down 43.8% year over year. That is above the sector sector average of $-9.6M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARDT's EBIT is now $230M (was $410M) — a 43.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ardent Health Partners is outperforming or lagging.

The its sector sector average EBIT is about $-9.6M. Ardent Health Partners is at $230M, which is higher that average. That is roughly 2516.4% above the sector mean. Use the comparison chart on this page to see how ARDT stacks up against individual peers as well.

Tracking ARDT's ebit over time shows whether Ardent Health Partners is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $410M in the prior-year period — down 43.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Ardent Health Partners's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $230M) with ownership activity and broader fundamentals.